Education
About Us
Working with TipRanks
Follow Us
Valerio Therapeutics (FR:ALVIO)
:ALVIO
ALVIO Stock Chart & Stats
€0.06
<€0.01(1.53%)
At close: 4:00 PM EST
€0.06
<€0.01(1.53%)
Day’s Range― - ―
52-Week Range€0.04 - €0.31
Previous CloseN/A
Volume8.86K
Average Volume (3M)2.81M
Market Cap
€84.91M
Enterprise ValueN/A
Total Cash (Recent Filing)€1.18M
Total Debt (Recent Filing)€13.44M
Price to Earnings (P/E)―
Beta-1.54
Next Earnings
Jul 24, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding488,847,870
10 Day Avg. Volume4,419,059
30 Day Avg. Volume2,810,885
Financial Highlights & Ratios
PEG Ratio-0.07
Price to Book (P/B)-1.29
Price to Sales (P/S)6.44
P/FCF Ratio-0.90
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
ALVIO FAQ
What was Valerio Therapeutics’s price range in the past 12 months?
Valerio Therapeutics lowest stock price was €0.04 and its highest was €0.31 in the past 12 months.
What is Valerio Therapeutics’s market cap?
Valerio Therapeutics’s market cap is €84.91M.
When is Valerio Therapeutics’s upcoming earnings report date?
Valerio Therapeutics’s upcoming earnings report date is Jul 24, 2025 which is 124 days ago.
How were Valerio Therapeutics’s earnings last quarter?
Currently, no data Available
Is Valerio Therapeutics overvalued?
According to Wall Street analysts Valerio Therapeutics’s price is currently Overvalued.
Does Valerio Therapeutics pay dividends?
Valerio Therapeutics does not currently pay dividends.
What is Valerio Therapeutics’s EPS estimate?
Valerio Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Valerio Therapeutics have?
Valerio Therapeutics has 488,847,870 shares outstanding.
What happened to Valerio Therapeutics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Valerio Therapeutics?
Currently, no hedge funds are holding shares in FR:ALVIO
Company Description
Valerio Therapeutics
Valerio Therapeutics (ALVIO) is a biopharmaceutical company focused on developing innovative therapies for the treatment of cancer and other serious diseases. The company operates primarily in the biotechnology sector, leveraging advanced research and development to create novel drug candidates aimed at improving patient outcomes. Valerio Therapeutics is dedicated to addressing unmet medical needs through its pipeline of targeted therapies and is committed to advancing healthcare through scientific innovation.
Technical Analysis
Hybrigenics SA Class A
―
TME Pharma N.V.
―
Biophytis SA
―
Theranexus SA
―
NFL Biosciences SA
―